ArticleJournal of experimental & clinical cancer research : CR2019

Hyper-activation of Aurora kinase a-polo-like kinase 1-FOXM1 axis promotes chronic myeloid leukemia resistance to tyrosine kinase inhibitors.

M Mancini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.